Video summary

This Enzyme Made 74-Year-Old Skin Tissue 30 Again

Main summary

Key takeaways

Science and Nature

Scientific concepts, discoveries, and nature/biology phenomena

1) Advanced glycation end products (AGEs) and “molecular rust”

  • Glycation (age-related damage) has long been described as irreversible in textbooks.
  • CML (carboxymethyllysine) is highlighted as one of the most common AGEs.
  • CML is associated with:
    • Wrinkles (skin aging)
    • Stiff arteries (vascular aging)
    • Atherosclerotic plaque formation (pathology risk)
  • Mechanistic framing:
    • CML can accumulate for decades on long-lived proteins (updated slowly), such as:
      • Collagen (skin and arteries)
      • Proteins in the eyes and kidneys
    • CML is described as “molecular rust” because it is stable and protein-bound, making it hard to remove.
  • Reported gap before this work:
    • No known effective enzyme could convert stable protein-bound CML back to normal lysine.

2) Discovery: engineered bacterial enzyme (CMLase) that reverses CML

  • A new study (Nature Communications, July 2026) is presented as showing reversal/removal of CML.
  • Starting point:
    • The researchers began with bacterial glycine oxidase–type enzymes.
    • Some variants could remove free-state CML, but not CML attached to peptides/proteins.
  • Key engineering strategy:
    • Screened enzyme diversity to find a structure with a more open active site allowing larger protein fragments to access the active site.
    • Reported search scope: >44,000 enzyme structures.
    • Then performed massive directed evolution/optimization:
      • Screened >500 million modified versions.
    • Selection criterion:
      • Bacteria were allowed to survive only if the enzyme successfully converted CML back to normal lysine.
    • After five engineering rounds, the final enzyme was named CMLase.
  • Reported biochemical outcome:
    • CMLase contains 15 amino acid substitutions and two amino acid deletions relative to the starting enzyme.
    • It removes the chemical group from damaged lysine and restores lysine.

3) Experimental evidence reported

  • In vitro lab tests on proteins (overnight treatment):
    • CML reduction ranges:
      • 52–97% reduction in detectable CML in:
        • Albumin
        • Collagen
        • Casein
        • Hemoglobin
        • Sheep eye-isolated proteins
    • Mass spectrometry mapping:
      • CML detected at 33 locations on albumin.
      • CMLase reduced CML at 30 of those sites.
      • Improvements:
        • >50% improvement in 21 locations
        • >90% improvement in 7 locations**
  • Ex vivo preserved human tissues (one donor per tissue type; not a clinical trial):
    • Lens proteins (64-year-old donor):
      • 45% decrease by mass spectrometry
      • 78% decrease by antibody test
    • Aorta sections (75-year-old donor):
      • >70% reduction in CML staining
    • Skin (74-year-old donor):
      • >55% reduction in CML staining
      • Reduced to a level reportedly below what was measured for skin of a 31-year-old donor
    • All effects described as occurring after one night, but not in living organisms.

4) Limitations / what the study does NOT yet prove

  • Not clinical evidence:
    • n = 1” style limitations (one donor per tissue type; multiple sites per donor).
  • Ex vivo constraints:
    • Preserved tissue in a dish has no blood flow, no living immune system, and no full physiological response.
  • No functional endpoints shown:
    • No direct evidence of improved arterial elasticity, eye function, reduced inflammation, or increased life expectancy.
  • Delivery problem remains:
    • The enzyme was not introduced into the actual living extracellular matrix.
    • Future in-body use may trigger immune reactions.
  • AGE specificity:
    • The work focuses on CML only, not other AGEs (e.g., glucosepane, noted as a major crosslinking AGE in aging collagen).

5) “How to use the knowledge” (lifestyle/biochemistry concepts)

While the enzyme is not usable yet, the video discusses ways to reduce AGE formation, centered on glycemic control and cooking chemistry.

A) Blood sugar regulation as a driver of glycation

  • Hyperglycemia can increase circulating/intracellular AGEs including CML.
  • Direct AGE measurement is said to be difficult; HbA1c (hemoglobin A1c) is used as an indirect marker.
  • Claim: carbohydrate intake alone doesn’t automatically cause glycation; the key is insulin sensitivity.

B) Strength training and glucose uptake

  • Exercise (especially strength training) increases muscle glucose uptake.
  • Strength training is presented as indirectly helpful for reducing glycation/AGE burden and for skin rejuvenation.

C) Timed eating / intermittent fasting

  • Example schedule given:
    • First meal ~10:00
    • Second meal ~16:00–17:00
  • Claim: keeping glucose lower for more of the day supports longevity pathways (as described in the video).

D) Cooking methods and AGE formation

  • High-temperature dry cooking (reported):
    • frying, broiling, baking → more AGEs
  • Moist-heat methods (reported to create fewer AGEs):
    • boiling, steaming, simmering, braising
  • Dietary AGE concentration claims:
    • Meats and fats cooked at high temperatures have the highest AGE levels.
    • Grilled/barbecued/deep-fried foods: most AGEs.
  • Absorption estimate:
    • Dietary AGEs: only ~10% absorbed (per the video), but can still add up.

E) Antioxidants to counter AGE effects

  • Suggestions:
    • Pair high-AGE foods with antioxidant-rich vegetables
    • Examples mentioned: vitamin C, vitamin E

6) Supplements and trials mentioned (general glycation rather than CML specifically)

  • Collagen and glycine are presented as helpful for lowering AGE-related measures.

2023 randomized controlled trial: marine collagen peptides

  • 5 g marine collagen peptides for 12 weeks
  • AGE change:
    • Collagen group: ~4.7% decrease
    • Placebo group: ~4.85% increase
  • Insulin sensitivity:
    • HOMA-IR decreased by:
      • ~18% in collagen group
      • ~10% in placebo group
  • AGE changes correlated with HOMA-IR changes.

Glycine in type 2 diabetes

  • 5 g glycine three times daily
  • HbA1c improvement:
    • Glycine group: from 8.3% → 6.9%
    • Placebo: from 8.0% → 7.6%
  • Claim/interpretation:
    • Glycine status is lower in people with higher HbA1c.

Meal-level glycemic effect

  • A single dose: 5 g glycine + 25 g glucose
  • Result claimed: >50% reduction in postprandial glucose response vs glucose alone.

Proposed role of glycine

  • Glycine may help regulate blood sugar and reduce glycation/AGE formation.

Additional glycine claims (as stated)

  • Raises glutathione
  • Neutralizes harmful effects of methionine on longevity (as claimed)
  • Supports creatine synthesis

Herbs mentioned for cooking-related AGE reduction

  • rosemary, thyme, parsley
  • Use suggested as a topping when cooking high-temperature meat

Researchers / sources featured

  • Researchers in a Nature Communications study (July 2026) (the video does not name individuals)
  • Journal source: Nature Communications (July 2026)
  • Mentioned experimental targets/sources (organisms/materials):
    • Bacterium: Calidithe Thermos Rosius (as written in subtitles; likely intended as a specific bacterial source for the enzyme)
    • Human tissue donors (ages mentioned): 64-year-old lens donor, 75-year-old aorta donor, 74-year-old skin donor, plus 31-year-old comparison skin (no names provided)
  • Clinical trial sources (no investigator names given in subtitles):
    • 2023 randomized controlled trial on marine collagen peptides (5 g for 12 weeks)
    • Type 2 diabetes glycine trial(s) (no named authors/affiliations provided)
    • A postprandial glucose study with glycine + glucose (no named authors/affiliations provided)

Original video